These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 168133)

  • 1. Cellular immunologic responsiveness to extracts of ovarian epithelial tumors.
    Melnick H; Barber HR
    Gynecol Oncol; 1975 Mar; 3(1):77-86. PubMed ID: 168133
    [No Abstract]   [Full Text] [Related]  

  • 2. An immunohistochemical study of distribution of carcinoembryonic antigen in epithelial tumours of the ovary.
    Heald J; Buckley CH; Fox H
    J Clin Pathol; 1979 Sep; 32(9):918-26. PubMed ID: 229130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of immunoglobulins in the effusions of human ovarian epithelial neoplasms.
    Kutteh WH; Gall SA; Doellgast GJ; Allitto BA; Dawson JR
    Am J Obstet Gynecol; 1984 Sep; 150(1):65-9. PubMed ID: 6476028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen isotypes in tissue sections and loose cyst fluid cells of ovarian neoplasms.
    Harłozińska A; Bar JK; Jothy S; Sedlaczek P; Slesak B; Richter R
    Tumour Biol; 1993; 14(1):1-8. PubMed ID: 7684152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
    Bhattacharya M; Barlow JJ
    Am J Obstet Gynecol; 1973 Nov; 117(6):849-53. PubMed ID: 4126800
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunofluorescence measurement of C1 inactivator (alpha 2 neuraminoglycoprotein) activity of the surface of human carcinoma cells.
    Osther K; Linnemann R
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Jun; 81(3):365-72. PubMed ID: 4360139
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell-mediated immunity in patients with ovarian carcinoma.
    Chen SY; Koffler D; Cohen CJ
    Am J Obstet Gynecol; 1973 Feb; 115(4):467-70. PubMed ID: 4346615
    [No Abstract]   [Full Text] [Related]  

  • 8. Carcinoembryonic antigen (CEA) in ovarian cancer: factors influencing its incidence and changes which occur in response to cytotoxic drugs.
    Khoo SK; MacKay EV
    Br J Obstet Gynaecol; 1976 Oct; 83(10):753-9. PubMed ID: 990213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced transplantability of human ovarian cancer lines in cyclophosphamide-pretreated nude mice.
    Nauta MM; Boven E; Schlüper HM; Erkelens CA; Pinedo HM
    Br J Cancer; 1986 Aug; 54(2):331-5. PubMed ID: 3017398
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cellular and humoral immunity in patients with benign tumors and tumor-like formations of ovaries].
    Selezneva ND; Kadagidze ZG; Andikian SI; Veskova TK; Zhogoleva IB
    Sov Med; 1982; (4):37-41. PubMed ID: 6980484
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary.
    Maughan TS; Fish RG; Shelley M; Jasani B; Williams GT; Adams M
    Gynecol Oncol; 1988 Jul; 30(3):342-6. PubMed ID: 2839394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cell-mediated immunity and blocking factor using a new line of ovarian cancer cells in vitro.
    Pattillo RA; Story MT; Ruckert AC
    Cancer Res; 1979 Apr; 39(4):1185-92. PubMed ID: 421202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum and tissue measurements of CA72-4 in ovarian cancer patients.
    Negishi Y; Iwabuchi H; Sakunaga H; Sakamoto M; Okabe K; Sato H; Asano G
    Gynecol Oncol; 1993 Feb; 48(2):148-54. PubMed ID: 8381375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ovarian tumour specific mucin antigen--immunohistological and biochemical studies.
    Ma J; Handley CJ; de Boer WG
    Pathology; 1983 Oct; 15(4):385-91. PubMed ID: 6371680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell activity and progression-free survival in ovarian cancer.
    Garzetti GG; Cignitti M; Ciavattini A; Fabris N; Romanini C
    Gynecol Obstet Invest; 1993; 35(2):118-20. PubMed ID: 8383627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
    Cruickshank DJ; Fullerton WT; Klopper A
    Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells.
    de Kretser TA; Thorne HJ; Jacobs DJ; Jose DG
    Eur J Cancer Clin Oncol; 1985 Sep; 21(9):1019-35. PubMed ID: 2998800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen in human ovarian neoplasms.
    Marchand A; Fenoglio CM; Pascal R; Richart RM; Bennett S
    Cancer Res; 1975 Dec; 35(12):3807-10. PubMed ID: 1192434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Distribution and diagnostic role of COTA in mucinous ovarian tumors].
    Shi ZL
    Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):191-2. PubMed ID: 2612330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OVARIAN TUMORS IN PREGNANCY.
    TAWA K
    Am J Obstet Gynecol; 1964 Oct; 90():511-6. PubMed ID: 14217653
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.